July 14, 2020
A proposed shareholder class announced a settlement with Insys Therapeutics' former CEO in Arizona federal court Tuesday, which would resolve securities fraud claims over the company's alleged kickbacks to doctors who prescribed an addictive opioid spray.
May 11, 2020
A proposed shareholder class announced a settlement with a former Insys Therapeutics executive in Arizona federal court on Friday, which would bring an end to securities fraud claims over the company's alleged kickbacks to doctors who prescribed an addictive opioid spray.
October 08, 2019
An Arizona federal judge sharply rebuked an Insys Therapeutics investor Tuesday for "not listening" to the court's position on the shareholder's request to excuse the beleaguered pharmaceutical company from a proposed securities class action over its bribery of doctors to prescribe an addictive opioid spray.